Related Experiment Videos
Internalization of monoclonal antibodies selected for immunotoxin activity against small-cell lung cancer
J K Weltman1, C L Melucci, J Chen
1Department of Medical Oncology, Rhode Island Hospital 02903.
Abstract:
Two hybridomas producing MOABs with anti-SCLC activity were selected for immunotoxin activity by an indirect screen and were twice cloned. Binding activity of the MOABs to SCLC cells was demonstrated by immunoperoxidase activity, which could be blocked by streptavidin. The MOABs mediated the internalization of a biotinylated Fab' anti-mouse Ig marker at 37 degrees C. Internalization of the biotinylated marker by the SCLC target cells resulted in protection of the marker from streptavidin-blocking. These results show that MOABs selected for immunotoxin activity against SCLC can mediate internalization of an antibody fragment with a mass about 50% greater than that of the toxin. MOABs selected for immunotoxin activity may be useful for delivering agents other than toxins to the inside of SCLC cells.
Insights
Monoclonal antibodies against small cell lung cancer (SCLC) can deliver molecules into cancer cells. This antibody-mediated internalization shows potential for targeted drug delivery beyond immunotoxins.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Small cell lung cancer (SCLC) remains a challenging malignancy with limited treatment options.
- Monoclonal antibodies (MOABs) are being explored for targeted cancer therapies.
- Developing effective delivery systems for therapeutic agents to SCLC cells is crucial.
Purpose of the Study:
- To evaluate the potential of monoclonal antibodies (MOABs) selected for immunotoxin activity against SCLC.
- To determine if these MOABs can mediate the internalization of non-toxin payloads into SCLC cells.
- To assess the utility of MOABs for targeted delivery of agents beyond traditional toxins.
Main Methods:
- Selection and cloning of hybridomas producing MOABs with anti-SCLC activity.
- Assessment of MOAB binding to SCLC cells using immunoperoxidase assays.
- Evaluation of MOAB-mediated internalization of a biotinylated Fab' anti-mouse Ig marker at 37°C.
- Streptavidin-blocking assays to confirm internalization.
Main Results:
- Selected MOABs demonstrated binding activity to SCLC cells, inhibitable by streptavidin.
- MOABs successfully mediated the internalization of a biotinylated marker into SCLC cells.
- Internalized markers were protected from streptavidin-blocking, confirming cellular uptake.
- The MOABs facilitated internalization of a marker significantly larger than typical toxins.
Conclusions:
- Monoclonal antibodies (MOABs) selected for immunotoxin potential can effectively mediate the internalization of antibody fragments into SCLC cells.
- These MOABs show promise for delivering therapeutic agents, not limited to toxins, into SCLC cells.
- This antibody-mediated internalization mechanism offers a novel strategy for targeted therapy in SCLC.